Johnson & Johnson upcoming earnings calendar, pharma group steadies on NYSE

By Daniel Hoffmann, Chart & Technicals desk. Reviewed prior to publication on 2026-06-30, 07:33.

Johnson & Johnson (US4781601046) enters late June with investors looking ahead to its next earnings dates and guidance updates. The New York-listed healthcare group trades on the NYSE as a long-established component of major U.S. benchmarks and sector indices.

Upcoming earnings dates and calendar

Johnson & Johnson typically reports its financial results on a quarterly basis, with scheduled releases for the first, second, third, and fourth quarters each year. The company traditionally provides details on sales, operating profit, and earnings per share alongside commentary on its pharmaceuticals, medical technology, and consumer health activities.

The timing of the next earnings release matters for investors tracking Johnson & Johnson shares, as quarterly updates often include revised guidance and commentary on pipeline progress in key therapeutic areas. Market participants also watch whether management adjusts full-year forecasts or offers new color on margin development and cash-flow trends.

Focus on analyst consensus and expectations

Analyst coverage of Johnson & Johnson generally centers on revenue growth in pharmaceuticals, the performance of its medical devices segment, and the stability of cash distributions via dividends. Many research houses follow the stock with long-term models, incorporating assumptions on patent expiries, new drug launches, and regulatory developments.

Consensus expectations around upcoming quarters typically reflect the mix of mature medicines, newer treatments, and device innovations in Johnson & Johnsons portfolio. Analysts compare the groups metrics with peers such as Pfizer, Merck, and Abbott Laboratories when assessing relative valuation and earnings quality.

What the company sells

Johnson & Johnson generates revenue through a diversified healthcare portfolio that spans prescription pharmaceuticals, medical devices, and consumer health products. The group markets medicines in areas such as oncology and immunology and supplies hospitals with surgical instruments and orthopedic implants, alongside well-known over-the-counter brands.

Where the stock trades today

Johnson & Johnson shares trade on the New York Stock Exchange in U.S. dollars. At the time of writing, a precise latest share price and timestamp are not cited here, but the listing remains one of the larger healthcare names on the NYSE.

This article was produced with AI assistance and editorially reviewed. Price and company figures without guarantee; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions carry risks up to and including total loss.